WuXi Biologics proudly established a cutting-edge biolog manufacturing facility in Dundalk, Republic of Ireland, with a significant investment of €325 million ($394 million). This state-of-the-art facility, which commenced construction in December 2018 and officially began operations in December 2021, stands as one of the first and largest greenfield projects undertaken by a Chinese company in Ireland. WuXi is dedicated to advancing biopharmaceutical development and manufacturing, enhancing global health outcomes.